Compare RNXT & WWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNXT | WWR |
|---|---|---|
| Founded | 2012 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4M | 126.2M |
| IPO Year | 2021 | N/A |
| Metric | RNXT | WWR |
|---|---|---|
| Price | $0.90 | $1.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $7.75 | $1.88 |
| AVG Volume (30 Days) | 334.6K | ★ 3.4M |
| Earning Date | 11-13-2025 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $928,000.00 | N/A |
| Revenue This Year | $2,795.35 | N/A |
| Revenue Next Year | $272.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.70 | $0.45 |
| 52 Week High | $1.50 | $3.75 |
| Indicator | RNXT | WWR |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 57.38 |
| Support Level | $0.89 | $1.08 |
| Resistance Level | $1.04 | $1.30 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 3.03 | 67.87 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.